DDX21 Antibodies

Santa Cruz Biotechnology delivers a wide array of DDX21 monoclonal antibodies for investigating DDX21 in cellular processes. DDX21 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DDX21, also known as RNA helicase II, plays a crucial role in RNA metabolism, including transcription, splicing, and ribosome biogenesis. DDX21's function is vital for maintaining cellular homeostasis and regulating gene expression, making it an important target for studies related to various diseases, including cancer and viral infections. Understanding DDX21 mechanisms can provide insights into therapeutic strategies and potential biomarkers. DDX21 monoclonal antibodies enable precise detection and analysis of DDX21 expression patterns across different cell types and tissues. Researchers can explore DDX21's role in RNA processing and its impact on cellular function through multiple experimental approaches. DDX21 monoclonal antibodies support detailed characterization of protein-protein interactions and subcellular localization patterns. Santa Cruz Biotechnology monoclonal antibodies for DDX21 contribute to advancing scientific knowledge in RNA biology and disease research.